Skip to main content

Tevogen Inc.

For the period ended Aug 3, 2026. Filed Aug 3, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Aug 3, 2026 · Filed Aug 3, 2026

TVGN$5.59+0.5%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐Preliminary Proxy Statement
☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒Definitive Proxy Statement
☐Definitive Additional Materials
☐Soliciting Material under §240.14a-12

Tevogen Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒No fee required
☐Fee paid previously with preliminary materials
☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

TEVOGEN INC.

15 Independence Boulevard, Suite #210

Warren, New Jersey

NOTICE OF 2026 ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD AT 1:30 p.m. EASTERN TIME ON AUGUST 24, 2026

MEETING LOCATION:

www.virtualshareholdermeeting.com/TVGN2026

Dear Tevogen Inc. Stockholder:

You are cordially invited to attend the 2026 Annual Meeting of the Stockholders (the “Annual Meeting”) of Tevogen Inc., formerly known as Tevogen Bio Holdings Inc. (the “Company”). The Annual Meeting will be held on August 24, 2026, commencing at 1:30 p.m. Eastern Time, and will be a completely virtual meeting of stockholders.

The items of business for the Annual Meeting are to:

1.Elect as Class II directors the two nominees named in the attached proxy statement to serve for a term of three years each, or until their respective successors are duly elected and qualified.

The Board of Directors recommends that you voteFOR the election of each director nominee.

2.Ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

The Board of Directors recommends that you voteFOR Proposal 2.

3.Approve an amendment to the Tevogen 2024 Omnibus Incentive Plan, as amended (the “2024 Plan”) to increase the number of shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), available for issuance thereunder by 100,000,000 (the “2024 Plan Amendment”).

The Board of Directors recommends that you voteFOR Proposal 3.

4.Approve an amendment to the Certificate of Incorporation of the Company, as amended (the “Charter”), to permit stockholder action by written consent (the “Written Consent Charter Amendment”).

The Board of Directors recommends that you voteFOR Proposal 4.

We will also transact any other business as may properly come before the meeting or any adjournment or postponement thereof.

The Annual Meeting will be held only via live webcast. We believe that the virtual meeting format expands stockholder access and participation and improves communications.

You will be able to attend and participate in the Annual Meeting online, vote your shares electronically, and submit your questions prior to and during the meeting by visiting:www.virtualshareholdermeeting.com/TVGN2026. To vote at the meeting, you must have your control number that is shown on your Notice of Internet Availability of Proxy Materials (“Notice”), voting instruction form, or proxy card. We encourage you to access the Annual Meeting prior to the start time to allow ample time for online check-in. The website will be open for check-in beginning at 1:15 p.m. Eastern Time on the date of the Annual Meeting.

Only stockholders of record at the close of business on July 23, 2026 are entitled to notice of and to vote at the Annual Meeting. Any person who was not a stockholder as of the record date may attend the Annual Meeting as an observer but will not be able to vote or ask questions.

We encourage you to attend the Annual Meeting, but it is important that your shares are represented at the Annual Meeting whether or not you plan to attend. To ensure that you will be represented, we ask you to vote online, by mail, or by phone as soon as possible, using one of the methods below.

We expect to commence mailing these proxy materials to our security holders on or about August 3, 2026.

Your Vote is Important

We encourage all stockholders of record to read the attached proxy statement with care and vote right away using any of the following methods, even if they intend to attend the Annual Meeting. If you plan to vote during the Annual Meeting, you may do so if you enter your “control number.” The control number is a 16-digit number that you can find in your voting instruction form (if you are a beneficial owner who received proxy materials by mail) or proxy card (if you are a stockholder of record who received proxy materials by mail), as applicable, at the time you log into the meeting atwww.virtualshareholdermeeting.com/TVGN2026. Please note, however, that if your shares are held of record by a broker, bank, or other nominee and you wish to vote at the meeting, you may need to obtain a proxy issued in your name from that record holder. Please contact your broker, bank, or other nominee for information about specific requirements if you would like to vote your shares at the meeting.

To vote online atwww.proxyvote.com, have the 16-digit control number available and then follow the instructions. Beneficial owners who do not have a control number should follow the instructions provided on the voting instruction card or otherwise provided by your bank, broker or other nominee.

Onlinewww.proxyvote.com
By PhoneIn the U.S. or Canada dial toll-free (800) 690-6903
By MailCast your ballot, sign your proxy card, and send in our prepaid envelope

Tevogen Inc.

By order of the Board of Directors,

Dr. Ryan Saadi

Chairperson of the Board of Directors, Director, and Chief Executive Officer

Warren, New Jersey, USA

August 3, 2026

Table of Contents

Cautionary Note Regarding Forward-Looking Statements1
Proxy Summary2
About Tevogen2
Voting Matters and Board Recommendations2
How to Vote2
Proposal No. 1 - Election of Directors3
Board of Directors3
Directors and Nominees3
Corporate Governance5
Composition of the Board5
Director Qualifications5
Director Independence5
Board Leadership Structure5
Role of Board in Risk Oversight6
Controlled Company Status6
Board Meetings and Committees6
Nomination of Directors8
Code of Business Conduct and Ethics8
Insider Trading Policy8
Communications with the Board of Directors8
Certain Relationships and Related Person Transactions8
Security Ownership of Certain Beneficial Owners and Management12
Director Compensation13
Executive Compensation14
Summary Compensation Table14
Narrative Disclosure to Summary Compensation Table15
Outstanding Equity Awards at Fiscal Year-End16
Anti-Hedging and Anti-Pledging Policy16
Policies and Practices Related to the Grant of Certain Equity Awards16
Equity Compensation Plan Information16
Proposal No. 2 - Ratification of Appointment of Independent Registered Public Accounting Firm17
Audit Fees17
Pre-Approval Policies and Procedures17
Audit Committee Report18
Proposal No. 3 - Amendment To the 2024 Plan to Increase the Number of Shares of Common Stock Available for Issuance19
Background19
Notable Features of the 2024 Plan19
Summary of the Material Terms of the 2024 Plan20
Certain Material U.S. Federal Income Tax Consequences25
Plan Benefits28
Explanation of Amendments28
Proposal No. 4 - Approval of an Amendment to the Company’s Certificate of Incorporation to Permit Stockholders to Act by Written Consent In Lieu of a Meeting29
Background29
Reasons for the Written Consent Charter Amendment29
Interests of the Controlling Stockholder30
Effectiveness of the Written Consent Charter Amendment if Approved30
Questions and Answers31
Additional Information35
Stockholder Proposals to be Included in Next Year’s Proxy Statement35
Stockholder Nominations and Proposals to be Brought Before Next Year’s Annual Meeting35
Householding36
Other Business36
Availability of Proxy Materials36
Annex A: 2024 Plan AmendmentA-1
Annex B: Certificate of Amendment to the Certificate of Incorporation of Tevogen Inc.B-1
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.